Long-term results of the Israeli National Studies in childhood acute lymphoblastic leukemia: INS 84, 89 and 98 (Q82269132)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20016534%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Long-term results of the Israeli National Studies in childhood acute lymphoblastic leukemia: INS 84, 89 and 98 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20016534%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

main subject

lymphoblastic leukemia

1 reference

B Stark

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20016534%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

R Nirel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20016534%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

G Avrahami

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20016534%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

A Abramov

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20016534%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

D Attias

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20016534%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

A Ballin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20016534%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

B Bielorai

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20016534%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Y Burstein

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20016534%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

H Gavriel

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20016534%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

R Elhasid

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20016534%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

J Kapelushnik

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20016534%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

D Sthoeger

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20016534%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

A Toren

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20016534%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

M Wientraub

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20016534%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

I Yaniv

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20016534%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

S Izraeli

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20016534%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

17 December 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20016534%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20016534%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20016534%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20016534%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

419-424

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20016534%20AND%20SRC:MED&resulttype=core&format=json

Acute lymphoblastic leukaemia

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.254

7 January 2021

Current management and challenges of malignant disease in the CNS in paediatric leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.254

7 January 2021

CNS-Directed Therapy for Childhood Acute Lymphoblastic Leukemia: Childhood ALL Collaborative Group Overview of 43 Randomized Trials

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.254

7 January 2021

Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.254

7 January 2021

High incidence of meningioma in cranial irradiated survivors of childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.254

7 January 2021

Effective preventive central nervous system therapy with extended triple intrathecal therapy and the modified ALL-BFM 86 chemotherapy program in an enlarged non-high risk group of children and adolescents with non-B-cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.254

7 January 2021

Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.254

7 January 2021

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.254

7 January 2021

Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster groups.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.254

7 January 2021

Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report fr

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.254

7 January 2021

Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.254

7 January 2021

Effects of chemotherapy on neurocognitive function in children with acute lymphoblastic leukemia: a critical review of the literature.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.254

7 January 2021